Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Moleculin Biotech Q1 EPS $(0.24) Down From $(0.20) YoY

Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(0.24) per share. This is a 20 percent decrease over losses of $(0.20) per share from the same period last year.
byBenzinga Newsdesk
May 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(0.24) per share. This is a 20 percent decrease over losses of $(0.20) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0